D

Day One Biopharmaceuticals
D

DAWN

7.77500
USD
0.72
(10.21%)
مغلق
حجم التداول
78,052
الربح لكل سهم
-1
العائد الربحي
-
P/E
-9
حجم السوق
796,408,279
الأخبار المقالات

العنوان: Day One Biopharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.